Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Sustained antibody response to a linear epitope of Nipah virus fusion protein in human survivor serum samples.

Tropical biomedicine·2026
Same author

Over-prescription of short-acting β<sub>2</sub>-agonists for asthma in South Africa: Results from the SABINA III study.

African journal of thoracic and critical care medicine·2023
Same author

Flower cells in patient with HTLV1 associated adult T-cell leukaemia/lymphoma.

QJM : monthly journal of the Association of Physicians·2019
Same author

Associations of pain and depression with marital status in patients diagnosed with Parkinson's disease.

Acta neurologica Scandinavica·2015
Same author

Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).

Journal of human hypertension·2015
Same author

Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study.

Diabetes, obesity & metabolism·2014

Video Experimental Relacionado

Updated: Jul 1, 2026

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart
07:59

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart

Published on: June 20, 2017

La endotelina plasmática en la insuficiencia cardíaca crónica.

J J McMurray1, S G Ray, I Abdullah

  • 1Department of Cardiology, Western Infirmary, Glasgow, UK.

Circulation
|April 1, 1992
PubMed
Resumen

Los pacientes con insuficiencia cardíaca crónica (ICC) presentan niveles elevados de endotelina circulante, un potente péptido vasoconstrictor. Estos aumentos en las concentraciones de endotelina en la insuficiencia cardíaca congestiva pueden desempeñar un papel importante en la fisiopatología de la enfermedad.

Más Videos Relacionados

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Videos de Experimentos Relacionados

Last Updated: Jul 1, 2026

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart
07:59

The Inverted Heart Model for Interstitial Transudate Collection from the Isolated Rat Heart

Published on: June 20, 2017

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Área de la Ciencia:

  • Fisiología cardiovascular fisiología cardiovascular.
  • Endocrinología Endocrinología.
  • Investigación de Neuropéptidos Investigación de Neuropéptidos

Sus antecedentes:

  • Las endotelinas son péptidos recientemente identificados conocidos por sus propiedades vasoconstrictoras.
  • La insuficiencia cardíaca crónica (ICC) se asocia con la vasoconstricción arterial periférica y renal.

Objetivo del estudio:

  • Para investigar los niveles plasmáticos de inmunoreactividad endotelínica en pacientes diagnosticados con insuficiencia cardíaca crónica (ICC).

Principales métodos:

  • Medición de las concentraciones plasmáticas de endotelinas venosas periféricas en pacientes con insuficiencia cardíaca congestiva grave y voluntarios sanos.
  • Evaluación de los niveles de endotelina durante el ejercicio.
  • Análisis de correlación con el factor natriurético auricular plasmático, la urea sérica y la creatinina sérica.
  • Evaluación de la extracción renal de la endotelina.

Principales resultados:

  • Los pacientes con insuficiencia cardíaca congestiva grave mostraron concentraciones plasmáticas de endotelinas significativamente más altas (12,4 +/- 0,6 pmol/l) en comparación con los controles sanos (6,4 +/- 0,3 pmol/l).
  • Los niveles plasmáticos de endotelina no cambiaron con el ejercicio en ninguno de los grupos.
  • No se encontró una correlación significativa entre la endotelina plasmática y el factor natriurético auricular, la urea o la creatinina en pacientes con CHF.
  • Se observó una extracción renal significativa de endotelina en pacientes con insuficiencia cardíaca congestiva.

Conclusiones:

  • Se sugiere que las concentraciones de endotelina circulante dentro del rango de 5-40 pmol/l son vasoactivas.
  • Es probable que los niveles elevados de endotelina detectados en pacientes con insuficiencia cardíaca congestiva tengan importancia fisiopatológica para el síndrome.